問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
林吉晉
下載
2019-02-01 - 2026-11-30
Condition/Disease
Test Drug
Participate Sites8Sites
Recruiting8Sites
2025-04-01 - 2032-12-31
Participate Sites5Sites
Recruiting5Sites
2023-08-01 - 2026-07-31
Participate Sites1Sites
Recruiting1Sites
2023-11-01 - 2026-07-31
2025-10-01 - 2027-07-31
2022-10-01 - 2025-07-31
2024-05-01 - 2028-12-31
Participate Sites4Sites
Recruiting4Sites
2022-01-01 - 2025-12-31
Participate Sites2Sites
Recruiting2Sites
2017-01-01 - 2019-12-31
Prostate Adenocarcinoma
[11C]Choline ([11C]Methyl-dimethyl-2-hydroxyethyl-ammonium), Glass vial with 40-331mCi of 11C choline in aqueous 0.9% sodium
2021-05-07 - 2023-06-15
Advanced Solid Tumors
AMG 650
Participate Sites3Sites
Recruiting3Sites
全部
